Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 50% on Wednesday . The company traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares traded hands during trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Stock Up 11.1 %
The firm has a 50 day moving average of C$0.07 and a 200-day moving average of C$0.06. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock has a market capitalization of C$13.95 million, a P/E ratio of -10.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Effectively Use the MarketBeat Ratings Screener
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- How to Start Investing in Real Estate
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Stock Sentiment Analysis: How it Works
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
